Product: Paracetamol, Caffeine, Phenylephrine HCl & Chlorpheniramine Maleate Tablets
Dosage form: Uncoated tablets
Use: Symptomatic relief of pain, fever and runny nose, subject to approved labeling
Therapeutic class: Analgesic / Antipyretic / Antihistamine combination
SKU: Paracetamol Caffeine Phenylephrine HCl CPM Tablets
Categories: Contract Manufacturer, Formulations Exporter India, Manufacturing Pharmaceutical Company India, Pharmaceutical Exporter India, Pharmaceutical Formulations India, Tablets Manufacturer, WHO GMP Certified Formulations
Paracetamol, Caffeine, Phenylephrine HCl & CPM Tablets is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.
Manufacturer (as supplied): Healthy Life Pharma Pvt. Ltd. Exporter (as supplied): Healthy Inc. Certification and product availability require verification.
Paracetamol, Caffeine, Phenylephrine Hydrochloride and Chlorpheniramine Maleate tablets combine four pharmacologically different ingredients in a single uncoated tablet. Paracetamol relieves pain and reduces fever; caffeine is a stimulant and may act as an analgesic adjuvant; chlorpheniramine (CPM) is a first-generation antihistamine for sneezing and runny nose; phenylephrine is a sympathomimetic ingredient historically used in oral decongestants.
Oral phenylephrine at commonly used doses has not demonstrated convincing effectiveness for nasal congestion, so this page does not promise nasal decongestion or total cold relief. Healthy Life Pharma Pvt. Ltd. and Healthy Inc are identified in the supplied company description as manufacturer and exporter respectively; product-specific authorizations and certifications require confirmation.
| Variant | Composition per uncoated tablet | Source / status |
|---|---|---|
| A | Paracetamol BP 325 mg + Caffeine BP 30 mg + Phenylephrine HCl BP 2.5 mg + Chlorpheniramine Maleate BP 2 mg | Explicitly listed composition; Sunset Yellow; excipients q.s. |
| B | Paracetamol BP 325 mg + Caffeine BP 15 mg + Phenylephrine BP 2.5 mg + Chlorpheniramine BP 2 mg | Explicitly listed composition; Tartrazine; exact salt forms to confirm |
| C — verify | Paracetamol 500 mg + Caffeine 30 mg + Phenylephrine Hydrochloride 2.5 mg + Chlorpheniramine Maleate 4 mg | Appears in extended description only; confirm with approved master formula and label before listing as available |
Dosage form: Uncoated tablets for explicitly listed A and B variants. Class: Analgesic/antipyretic + stimulant + sympathomimetic + antihistamine. SKU: Paracetamol Caffeine Phenylephrine HCl CPM Tablets. Packaging, shelf life, pharmacopoeial compliance and availability depend on actual registered product.
Development of multi-ingredient tablets should address uniform distribution of low-dose phenylephrine and chlorpheniramine, compatibility of active ingredients, excipient selection, stability and suitable packaging. Validated blending and content-uniformity controls are especially important when active strengths differ substantially.
Specific claims about granulation equipment, process temperatures, humidity, coating or packaging material must be supported by batch manufacturing records and product development data.
Quality control should follow the applicable approved specification and include identification and assay of each active ingredient, dosage-unit uniformity, dissolution or disintegration as applicable, impurities, stability and packaging integrity. Numerical acceptance criteria are method- and product-specific and should not be published without the relevant approved specifications.
Paracetamol: analgesic and antipyretic, not an NSAID. Caffeine: central nervous system stimulant and potential analgesic adjuvant. Chlorpheniramine maleate: sedating antihistamine that may relieve sneezing and rhinorrhea. Phenylephrine HCl: oral decongestant ingredient whose effectiveness at typical oral doses is disputed.
Such combinations may be marketed for symptomatic cold-related fever, headache and runny nose where locally authorized. They do not treat the underlying viral infection. The inclusion of caffeine does not eliminate chlorpheniramine-related drowsiness.
Business customers can enquire about formulation options, minimum order quantities, packaging, contract manufacturing, country-specific regulatory dossiers and shipping terms. WHO-GMP status, Star Export House recognition, CTD/ACTD availability, COPP, FSC and COA should be confirmed using current product-specific documents before commercial publication or tender submission.
What is CPM? CPM means chlorpheniramine maleate, a first-generation antihistamine.
Does caffeine prevent sleepiness? No. Chlorpheniramine can impair alertness even when caffeine is present.
Are all listed strengths available? Variants A and B are supported by the supplied compositions. The 500 mg/30 mg/2.5 mg/4 mg combination appears only in descriptive text and requires confirmation.
Is phenylephrine effective for a blocked nose? Evidence does not establish meaningful nasal decongestion from standard oral phenylephrine doses; review local regulatory requirements and product labeling.
Use only according to the approved package insert or prescriber instructions for the specific country, strength, age group and formulation. Do not apply a generic dosing schedule across different four-ingredient products. Avoid taking additional paracetamol-containing cold or pain products concurrently, and seek pharmacist or medical advice before combining with other stimulants or antihistamines.
Important risks: paracetamol overdose can cause severe, potentially fatal liver injury; chlorpheniramine can cause drowsiness, dry mouth, blurred vision and urinary retention; caffeine can cause insomnia, anxiety and palpitations; phenylephrine may increase blood pressure or cause palpitations.
Extra care is needed with cardiovascular disease, hypertension, glaucoma, urinary retention, liver disease, pregnancy, breastfeeding and medicines such as monoamine oxidase inhibitors. Seek urgent medical care for suspected paracetamol overdose, severe allergic reaction or serious adverse symptoms. Do not drive if sleepy or dizzy.
Store according to the final approved product label in the original container, protected from inappropriate heat and moisture, and out of reach of children. A fixed storage temperature or 36-month shelf life should not be stated without approved stability data.
Product information is for B2B reference only and is not a substitute for the locally approved label or professional medical advice. Related paracetamol-only, ibuprofen, diclofenac, caffeine-only and orphenadrine combinations are separate formulations and should not be presented as the same four-ingredient tablet.